What the changes say
- New risks emphasize dependence on pharmacy chains, consumer trust, AI, restructuring, strategic transactions, and concentrated control.
- Privacy, intellectual-property, ESG, and governance risks receive greater or newly explicit attention.
- Dropped risks reduce emphasis on prescription concentration, PBM consolidation, regulatory change, ESG activism, and ownership effects on sale premiums.
What changed since the prior 10-K
New
- NewRisks Related to Our Business
These pharmacy chains represent a significant portion of overall prescription medication transactions in the United States
Revenue depends heavily on a limited number of pharmacy chains, whose closures or service disruptions could raise costs and interrupt prescription processing.
- NewRisks Related to Our Business
We may be unable to maintain a positive perception regarding our platform or maintain and enhance our brand
Poorer perceived discount prices or telehealth quality, weaker marketing investment, or negative publicity could damage GoodRx’s brand and consumer acquisition.
- NewRisks Related to Our Business
The harm may be immediate without affording us an opportunity for redress or correction and could have a material adverse effect on our business, financial condition, results of operations, and prospects
Inaccurate collection, breaches, or unlawful use of email addresses, phone numbers, and other consumer data could trigger claims and operational changes.
- NewRisks Related to Our Business
We use and may expand our use of AI and machine learning in our business and challenges with properly managing their use could result in reputational harm, competitive harm and legal liability, and adversely affect our results of operations
Inaccurate, biased, insecure, or controversial AI and machine-learning applications could cause reputational damage, legal liability, or competitive losses.
- NewRisks Related to Our Business
We may be unable to realize expected benefits from our restructuring and cost reduction efforts and our business might be adversely affected
Restructuring and workforce reductions may create implementation delays, operational disruption, lost expertise, weaker morale, and ineffective redistribution of responsibilities.
- NewRisks Related to Our Business
From time to time, we may pursue dispositions or other strategic transactions. Dispositions and other strategic transactions may not have the anticipated impact on our business, may negatively impact revenues and may make it difficult to generate cash flows to meet our cash requirements
Acquisitions, dispositions, or strategic relationships may fail to meet expectations, integrate effectively, support revenue, or generate cash for company needs.
- NewRisks Related to Our Business
ESG initiatives could increase our costs, harm our reputation, and adversely impact our financial results
Stakeholder demands and voluntary ESG initiatives could increase compliance, disclosure, and operating costs while creating reputational or financial harm.
- NewRisks Related to Intellectual Property
We may be sued by third parties for infringement, misappropriation, dilution, or other violations of their intellectual property or proprietary rights
Internet, advertising, and e-commerce companies may assert patent, copyright, trademark, or trade-secret claims against GoodRx.
- NewRisks Related to Intellectual Property
Our competitors may also independently develop similar technology. Effective patent, trademark, copyright, and trade secret protection may not be available to us in every jurisdiction in which our solutions or technology are hosted or available
Weak or unavailable intellectual-property protection could let competitors copy GoodRx technology or cause GoodRx to lose rights through litigation.
- NewRisks Related to Our Organizational Structure, including Agreements and Relationships with Significant Stockholders
The parties to our stockholders agreement, who hold a significant portion of our Class B common stock, control the direction of our business and such parties’ ownership of our common stock prevents you and other stockholders from influencing significant decisions
Class B holders control approximately 95.6% of voting power, while stockholders agreement parties hold approximately 93.8% and influence board nominations.
- NewRisks Related to Our Organizational Structure, including Agreements and Relationships with Significant Stockholders
We are a “controlled company” under the corporate governance rules of The Nasdaq Stock Market and, as a result, qualify for, and rely on, exemptions from certain corporate governance requirements. You do not have the same protections afforded to stockholders of companies that are subject to such requirements
As a controlled company, GoodRx may rely on Nasdaq exemptions from independent-board, director-nomination, and compensation-committee requirements.
Dropped
- DroppedRisks Related to Our Business
We rely significantly on our prescription transactions offering and may not be successful in expanding our offerings within our markets, particularly the U.S. prescriptions market, or to other segments of the healthcare industry
- DroppedRisks Related to Our Business
Consolidation of PBMs or the loss of a PBM could negatively impact the discounts and prices that we present through our platform and may result in less competitive discounts and prices on our platform
- DroppedRisks Related to Our Business
A variety of federal and state laws, regulations and regulatory interpretations govern the collection, use, retention, sharing and security of consumer data, particularly in the context of online advertising, which we rely upon to attract new consumers
- DroppedRisks Related to Our Business
To the extent we are subject to such activism, it may require us to incur costs or otherwise adversely impact our business
- DroppedRisks Related to the Healthcare Industry
New and changing laws, regulations, executive orders and other governmental actions, particularly from the new presidential administration, may also create uncertainty about how laws and regulations will be interpreted and applied
- DroppedRisks Related to Our Organizational Structure, including Agreements and Relationships with Significant Stockholders
The concentration of ownership could deprive investors of an opportunity to receive a premium for their shares of Class A common stock as part of a sale of our company and ultimately might affect the market price of our Class A common stock
Reworded
- 100% rewrittenRisks Related to Our Business
Though we have wound down vitaCare Prescription Services, Inc.’s ("vitaCare") principal operations, vitaCare's past activities could be subject to regulation and enforcement by the federal government and the states in which vitaCare conducted its business, including state licensing of pharmacies and pharmacists
The risk shifts from broad evolving legal and privacy obligations to specific enforcement proceedings that may impose penalties, compliance costs, data-practice changes, publicity, and weaker demand.
- 82% rewrittenRisks Related to Our Business
We face the risk of litigation resulting from unauthorized text messages sent in violation of the Telephone Consumer Protection Act
No substantive change; the TCPA text-message litigation risk is unchanged apart from punctuation.
- 68% rewrittenRisks Related to Our Organizational Structure, including Agreements and Relationships with Significant Stockholders
Our capital structure may adversely affect the trading market for our Class A common stock
No substantive change; the dual-class structure may reduce or increase volatility in Class A shares and limit index inclusion.
- 68% rewrittenRisks Related to the Healthcare Industry
Our telehealth related products and services and relationships with our affiliated physician-owned professional entities may implicate laws governing the practice of medicine and fee-splitting
The description is shortened to state the state-law risks governing telehealth, physician control, and fee-splitting, without the prior compliance assurances and future-law discussion.
Was: Our telehealth offering and relationships with our affiliated physician-owned professional entities may implicate laws governing the practice of medicine and fee-splitting
- 61% rewrittenRisks Related to Our Business
We may be unable to successfully respond to changes in the market for prescription pricing, and may fail to maintain and expand the use of GoodRx codes through our apps and websites
No substantive change; the risk remains that consumer demand may not continue shifting toward digital prescription discounts.
- 59% rewrittenRisks Related to Our Business
We are subject to a series of risks related to climate change
No substantive change; climate-related disruptions, operating costs, and catastrophic weather remain the stated risks.
- 56% rewrittenRisks Related to Our Business
We depend on our information technology systems, and those of our third-party vendors, contractors, and consultants, and any failure or significant disruptions of these systems, security breaches or loss of data could materially adversely affect our business, financial condition and results of operations
The description updates security safeguards from physical, electronic, and organizational measures to physical, technical, and organizational measures and capitalizes Confidential Information.
- 47% rewrittenRisks Related to Our Business
Use of social media, emails, and text messages may adversely impact our reputation, subject us to fines or other penalties or be an ineffective source to market our offerings
The marketing-channel risk now expressly includes potential litigation and other damages or penalties, in addition to reputational harm and fines.
- 46% rewrittenRisks Related to the Healthcare Industry
Congress has and is likely to continue to scrutinize key participants in the healthcare industry, including PBMs. A number of bills have been introduced in Congress that would further regulate PBMs and impose additional requirements
- 41% rewrittenRisks Related to Our Organizational Structure, including Agreements and Relationships with Significant Stockholders
Substantial future sales by the parties to our stockholders agreement or other holders of our common stock, or the perception that such sales may occur, could depress the price of our Class A common stock
- 38% rewrittenRisks Related to Our Business
We may be unable to continue to attract, acquire, and retain consumers, or may fail to do so in a cost-effective manner
- 26% rewrittenRisks Related to Our Limited Operating History and Historical Growth Rates
Our results of operations vary and may fluctuate significantly from period-to-period
- 23% rewrittenRisks Related to Our Business
General economic factors, natural disasters, or other unexpected events may adversely affect our business, financial performance and results of operations
All 73 risk factors
Headings as the filing states them, in filing order.
Risks Related to Our Limited Operating History and Historical Growth Rates
- 01Our limited operating history and our evolving business make it difficult to evaluate our future prospects and the risks and challenges we may encounter
- 02Our historical growth rates may not be sustainable or indicative of future growth
- 03Our results of operations vary and may fluctuate significantly from period-to-period26% rewritten
- 04We may be unable to manage our future growth effectively, which could make it difficult to execute our business strategy
Risks Related to Our Business
- 05We may be unsuccessful in achieving broad market education and changing consumer purchasing habits
- 06We may be unable to continue to attract, acquire, and retain consumers, or may fail to do so in a cost-effective manner38% rewritten
- 07Our business is subject to changes in medication pricing and is significantly impacted by pricing structures negotiated by industry participants
- 08We generally do not control the categories and types of prescriptions for which we can offer savings or discounted prices
- 09We rely on a limited number of industry participants
- 10These pharmacy chains represent a significant portion of overall prescription medication transactions in the United StatesNew
- 11The impact of the changing retail pharmacy landscape is currently unknown, but may adversely affect our business, financial condition, and results of operations
- 12We operate in a very competitive industry and we may fail to effectively differentiate our offerings and services from those of our competitors, which could impair our ability to attract and acquire new consumers and retain existing consumers
- 13Our estimated addressable market is subject to inherent challenges and uncertainties. If we overestimate the size of our addressable market or the various markets in which we operate, our future growth opportunities may be limited
- 14We calculate certain operational metrics using internal systems and tools and do not independently verify such metrics. Certain metrics are subject to inherent challenges in measurement, and real or perceived inaccuracies in such metrics may harm our reputation and negatively affect our business
- 15Our telehealth related products and services are dependent on our ability to maintain our relationship with our telehealth provider network, including our affiliated professional entities, and the ability of such entities to recruit qualified telehealth providers
- 16Negative media coverage could adversely affect our business
- 17We may be unable to successfully respond to changes in the market for prescription pricing, and may fail to maintain and expand the use of GoodRx codes through our apps and websites61% rewritten
- 18We may be unable to maintain a positive perception regarding our platform or maintain and enhance our brandNew
- 19Our compliance with Section 404 requires that we incur substantial costs and expend significant management efforts
- 20Use of social media, emails, and text messages may adversely impact our reputation, subject us to fines or other penalties or be an ineffective source to market our offerings47% rewritten
- 21The harm may be immediate without affording us an opportunity for redress or correction and could have a material adverse effect on our business, financial condition, results of operations, and prospectsNew
- 22We rely on information technology to operate our business and maintain competitiveness, and must adapt to technological developments or industry trends
- 23We depend on the use of information technologies and systems. As our operations grow, we must continuously improve and upgrade our systems and infrastructure while maintaining or improving the reliability and integrity of our infrastructure
- 24We depend on our information technology systems, and those of our third-party vendors, contractors, and consultants, and any failure or significant disruptions of these systems, security breaches or loss of data could materially adversely affect our business, financial condition and results of operations56% rewritten
- 25We use and may expand our use of AI and machine learning in our business and challenges with properly managing their use could result in reputational harm, competitive harm and legal liability, and adversely affect our results of operationsNew
- 26We are subject to general business regulations and laws specifically governing the internet and e-commerce
- 27Our business relies on email, mail, and other messaging channels and any technical, legal or other restrictions on the sending of such correspondence or a decrease in consumer willingness to receive such correspondence could adversely affect our business
- 28We face the risk of litigation resulting from unauthorized text messages sent in violation of the Telephone Consumer Protection Act82% rewritten
- 29Though we have wound down vitaCare Prescription Services, Inc.’s ("vitaCare") principal operations, vitaCare's past activities could be subject to regulation and enforcement by the federal government and the states in which vitaCare conducted its business, including state licensing of pharmacies and pharmacists100% rewritten
- 30We may be unable to realize expected benefits from our restructuring and cost reduction efforts and our business might be adversely affectedNew
- 31Our ability to utilize our net operating loss carryforwards and certain other tax attributes may be limited
- 32We rely on the performance of members of management and highly skilled personnel, and if we are unable to attract, develop, motivate and retain well-qualified employees, our business could be harmed
- 33Any pandemic, endemic, or other infectious disease may adversely affect our business, results of operations, and financial condition by changing the way our consumers access healthcare and utilize our platform, or by causing us to modify our business practices
- 34General economic factors, natural disasters, or other unexpected events may adversely affect our business, financial performance and results of operations23% rewritten
- 35From time to time, we may pursue dispositions or other strategic transactions. Dispositions and other strategic transactions may not have the anticipated impact on our business, may negatively impact revenues and may make it difficult to generate cash flows to meet our cash requirementsNew
- 36Restrictions in our debt arrangements could adversely affect our operating flexibility, and failure to comply with any of these restrictions could result in acceleration of our debt
- 37Our business depends on network and mobile infrastructure and our ability to maintain and scale our technology
- 38A key element of our strategy is to generate a significant number of visitors to, and their use of, our apps and websites
- 39Some of our vendor agreements may be unilaterally terminated by the licensor for convenience, including with respect to services provided by Google, and if such agreements are terminated, we may not be able to enter into similar relationships in the future on reasonable terms or at all
- 40We rely on third-party platforms such as the Apple App Store and Google Play App Store, to distribute our platform and offerings
- 41We rely on software-as-a-service (“SaaS”) technologies from third parties
- 42We depend on our relationships with third parties and would be adversely impacted by system failures or other disruptions in the operations of these parties
- 43We are subject to a series of risks related to climate change59% rewritten
- 44ESG initiatives could increase our costs, harm our reputation, and adversely impact our financial resultsNew
Risks Related to Intellectual Property
- 45We may be unable to establish, maintain, protect, and enforce our intellectual property and proprietary rights or prevent third parties from making unauthorized use of our technology
- 46We may be sued by third parties for infringement, misappropriation, dilution, or other violations of their intellectual property or proprietary rightsNew
- 47Third parties have asserted, and may in the future assert, that we have infringed, misappropriated, or otherwise violated their intellectual property rights
- 48Our competitors may also independently develop similar technology. Effective patent, trademark, copyright, and trade secret protection may not be available to us in every jurisdiction in which our solutions or technology are hosted or availableNew
- 49We may be unable to continue the use of our trademarks, trade names, or domain names, or prevent third parties from acquiring and using trademarks, trade names, and domain names that infringe on, are similar to, or otherwise decrease the value of our brands, trademarks, or service marks
- 50If we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed
- 51Issued patents covering our offerings could be found invalid or unenforceable if challenged
- 52We utilize open source software, which may pose particular risks to our proprietary software and solutions
- 53If we fail to comply with our obligations under license or technology agreements with third parties, we may be required to pay damages and we could lose license rights that are critical to our business
Risks Related to the Healthcare Industry
- 54Our telehealth related products and services are subject to various state laws and regulations governing the provision of telehealth services
- 55Our telehealth related products and services and relationships with our affiliated physician-owned professional entities may implicate laws governing the practice of medicine and fee-splitting68% rewritten
- 56Congress has and is likely to continue to scrutinize key participants in the healthcare industry, including PBMs. A number of bills have been introduced in Congress that would further regulate PBMs and impose additional requirements46% rewritten
Risks Related to Our Organizational Structure, including Agreements and Relationships with Significant Stockholders
- 57Our capital structure may adversely affect the trading market for our Class A common stock68% rewritten
- 58The parties to our stockholders agreement, who hold a significant portion of our Class B common stock, control the direction of our business and such parties’ ownership of our common stock prevents you and other stockholders from influencing significant decisionsNew
- 59Substantial future sales by the parties to our stockholders agreement or other holders of our common stock, or the perception that such sales may occur, could depress the price of our Class A common stock41% rewritten
- 60We are a “controlled company” under the corporate governance rules of The Nasdaq Stock Market and, as a result, qualify for, and rely on, exemptions from certain corporate governance requirements. You do not have the same protections afforded to stockholders of companies that are subject to such requirementsNew
- 61Delaware law and provisions in our amended and restated certificate of incorporation and amended and restated bylaws could make a merger, tender offer or proxy contest more difficult, limit attempts by our stockholders to replace or remove our current management and limit the market price of our Class A common stock
- 62Our amended and restated certificate of incorporation provides that the doctrine of “corporate opportunity” does not apply with respect to certain parties to our stockholders agreement and any director or stockholder who is not employed by us or our subsidiaries
- 63We do not intend to pay dividends for the foreseeable future
- 64We are a holding company and depend on our subsidiaries for cash to fund operations and expenses, including future dividend payments, if any
General Risk Factors
- 65We may be unable to accurately forecast revenue and appropriately plan our expenses in the future
- 66We may experience fluctuations in our tax obligations and effective income tax rate, which could materially and adversely affect our results of operations
- 67We may need additional capital in the future, which may not be available to us on favorable terms, or at all, and may dilute your ownership of our Class A common stock
- 68Changes in U.S. patent law could diminish the value of patents in general, thereby impairing our ability to protect our platform or features of our platform and offerings
- 69We may not be able to enforce our intellectual property rights throughout the world
- 70We may be subject to claims that our employees, consultants, or advisors have wrongfully used or disclosed alleged trade secrets of their current or former employers or claims asserting ownership of what we regard as our own intellectual property
- 71If we cannot license rights to use technologies on reasonable terms, we may not be able to commercialize new solutions or services in the future
- 72Our stock price may be volatile or may decline regardless of our operating performance, resulting in substantial losses for investors
- 73The stock market has recently experienced extreme price and volume fluctuations. The market prices of securities of companies have experienced fluctuations that often have been unrelated or disproportionate to their results of operations
Other GoodRx Holdings 10-Ks
- FY2024 10-K risk factors68 risks
The business remains heavily exposed to prescription transactions, negotiated pricing, PBMs and national pharmacy chains.
Filed Feb 27, 2025
About this page
The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.